CTLA-4 (Ipilimumab Biosimilar) Antibodies
(CTLA-4 (Ipilimumab Biosimilar))
This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. [provided by RefSeq, Jul 2008].
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Recommended CTLA-4 (Ipilimumab Biosimilar) Antibodies
Synonyms and alternative names related to CTLA-4 (Ipilimumab Biosimilar)
cytotoxic T-lymphocyte associated protein 4 (CTLA4), CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12Protein level used designations for CTLA-4 (Ipilimumab Biosimilar)
- CD152 isoform
- celiac disease 3
- cytotoxic T lymphocyte associated antigen 4 short spliced form
- cytotoxic T-lymphocyte antigen 4
- cytotoxic T-lymphocyte protein 4
- cytotoxic T-lymphocyte-associated antigen 4
- cytotoxic T-lymphocyte-associated serine esterase-4
- ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
You are here:
